We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.10 | 9.70 | 10.50 | 10.10 | 9.975 | 10.10 | 211,828 | 08:00:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.83 | 93.71M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/8/2018 12:05 | Gash- AND 'a BB where folks, more often than not... are able to get things RIGHT ??? | the real lozan | |
23/8/2018 12:03 | Tosh, You're making some big assumptions. Firstly, I don't think DE's departure had anything to do with any disagreement on strategy, he left at least 2 or 3 years after the decision to retain Moditope within the company was taken. Secondly you are just assuming that the fact that DE left means that he was the one who wanted to split it off but that completely ignores the difference in their roles and the fact that DE also resigned from the board of several other companies at around the same time. As you say, we'll just never know and it's all speculation but the opportunity to spin Moditope off into a separate company was a moment in time. Once funds were raised to develop the product, patents filed under Scancell and the tech was taken forward the cost / benefit analysis of spinning it out changes dramatically. So you can't draw any conclusions from the fact that it remains under the Scancell umbrella today. | bermudashorts | |
23/8/2018 12:00 | Another question.... Would someone be more likely to invest if they saw: 1. A healthy, balanced BB discussing all the pros and cons, the history, the science, trial results, scientific papers, the potential profit, the potential risks. or 2. A BB dominated by someone who wants to dictate who can post and what they can discuss? | gazza | |
23/8/2018 11:57 | Inan, You must be able to see why you wind people up. You said: " and what is achieved by this speculation ? " Why can't other people speculate and discuss things? It's OK for you to speculate on the share price, speculate on the timing of the share price, speculate on the future structure of the company, speculate on the trial results, speculate on the efficacy of the science, speculate on the competitors respone..... etc etc but it's not OK for ANYONE ELSE to! Answer me a simple question: Is it the people or the topic that you object to? Or both? | gazza | |
23/8/2018 11:36 | And like a bad smell, just as welcome as a wasp at a picnic AGAIN | the real lozan | |
23/8/2018 11:20 | And like a bad smell, it appears from nowhere. FYI It was around this time that you said that £1 was " on the cards " eg imminent, so one would like to think that as your £1 is still a million miles away from coming to fruition, some 5 years later, that you may want to diagnose, as to where and how you got it so wrong. | tosh123 | |
23/8/2018 11:18 | yes, let's build some bridges | gazza | |
23/8/2018 10:56 | Agree Tosh i don't want to get involved as you have stated """I doubt that we will never really know the true facts though.""" so why would any one want to discuss what happened in 2013 area without knowing the facts and what is achieved by this speculation ? Nothing carry on pontificating | inanaco | |
23/8/2018 10:48 | Agema, anything is possible, maybe there was a bit of poetic license, i cant be sure. But there was something involving money and a polar disagreement between the two of them, of that im relatively certain. I doubt that we will never really know the true facts though. Lets just rejoice in the fact that we can discuss such matters without any nonsense from Voldermort. | tosh123 | |
23/8/2018 10:36 | Tosh If there was any kind of deal or money on the table. There would have to be an RNS and shareholders would be entitled to a vote. I cannot see how your source can be right on that. But I am sure a disagreement between RG and DE very possible and probable.Perhaps your source took a bit of fact and made a bit up.? | agema | |
23/8/2018 10:22 | WW, there are no lessons to be learnt here other than to do the exact opposite of what the caped crusader tells you, but i will leave that now. As far as RG making the right decision, IMHO we already know that to a certain extent, hence the last 4 years of stagnation, but i also agree with you, in that we cant really be sure without knowing the specific details of any agreement, or not, as the case may be. Agema, you could be right with what you say, all i can confirm is that there was some kind of deal / money potentially on the table, and that RG and DE, had different views ( according to my source ). All a bit speculative, but nice to discuss anyway. As they say, there's no smoke without fire. | tosh123 | |
23/8/2018 10:17 | WW From memory. It came from I think, RG. He either tweeted it, or it came at an AGM. Possible it might be in a past RNS buried somewhere. But it was DEFINITELY put out there. Of course the claim cannot be verified. You have to take him at his word. | agema | |
23/8/2018 10:11 | "confused with the fact that supposedly"... I get the impression there are few facts involved in this discussion. | wigwammer | |
23/8/2018 10:06 | No folks. There was never any offer on the table. You might be getting confused with the fact that supposedly a reccomendation was put to a Pharmas board of Directors, to buy or invest in the company. But the reccomendation was turned down at Boardroom level. | agema | |
23/8/2018 09:59 | Ok tosh, even though I'm supposed to stick around here to learn my CERTAIN lesson, I'm sure the reference was directed elsewhere. Regarding partnership for scib1 - it is concerning that management disagreed over the direction of the company, but encouraging that a commercial deal was an option. 5 years later, with positive clinical data, the asset may achieve a significantly better price. RG may or may not have made the correct decision - difficult to know without seeing the economics of the deal. Genuine thanks for the input though. WW | wigwammer | |
23/8/2018 09:56 | Bermuda, " RG managed to get NDA's signed " are you suggesting they have added some sort of value. After advising Investors that they had entered into NDA's he then gave a long presentation of the process giving the impression a deal would be forthcoming. This was a minimum of 3 years ago and yet not one deal has been signed. The bloke has pulled the wool over Investors eyes for far too long. Another example of his misleading of Investors along with all his tweets highlighting deals signed by other small Pharmas and highlighting Market Caps of other Pharmas. How on earth can he compare Scancell to these other Companies who have actually signed a deal and have Market Caps a million miles from ours. The bloke is quite simply a fraud who has pocketed massive pay rises in his last couple of years which were paid for by Investors who have seen their Portfolios devastated. He has zero ethics , morals and treats his Investors with nothing but contempt. What other CEO would pat himself on the back for raising funds at 10p knowing that Investors had paid up to 60p for shares. This is why the man is nothing short of a disgrace. | panama7 | |
23/8/2018 09:44 | Why blame Directors.? The simple fact is. Nobody was interested in buying Scancell, hence no sale. I would look more at the data than Directors. The data was not good enough to tempt the big pharmas. A Director cannot sell, if nobody wants to buy. IMHO. Have a good day folks. | agema | |
23/8/2018 09:21 | Don’t want to enter debate over BOD as don’t feel qualified. But echo all Toshs and Logan’s thoughts about the Orrible Littke Man. He has cost people dearly with his LIES that is all we seek to expose here with balanced postings to him and his GANG. We will not be silenced except if he were to disappear from these boards and/ or apologise for all his deceitful ways or ADMIT he has issues and is actively seeking help to o ercone these difficulties. | drdobson1 | |
23/8/2018 09:17 | Boom, who knows what the real truth is, its all Chinese whispers. But it does give some credibility to the story, even though you heard the reverse, clearly there was a difference of opinion and one had to go. What i would say though is, the fact that the company remains as it was, does suggest to me that what i heard is correct, eg ;- DE wanted to split the company, otherwise, if it was RG who wanted to split, one assumes that RG would have subsequently done it. Who knows though. As far as the offer is concerned, the rules, as far as i can remember, is that not all offers only need to be put to the shareholders, but i will look that up again. | tosh123 | |
23/8/2018 08:54 | Tosh, Interesting, as I had heard the complete opposite - RG wanted to split and DE didn't but of course we'll never know. I have never heard that there was an offer on the table. Surely if there was they would have had to put it to shareholders? Despite the dreadful sentiment around cancer vaccines, RG managed to get NDA's signed. He also secured funding to allow LD to continue to develop the science without having to give away warrants left right and centre (unlike others!). If pharmas weren't prepared to sign on the dotted line then I'm not sure what else he could have done. Lozan, Yes, I'm sure he very much regrets that one! | bermudashorts | |
23/8/2018 08:53 | WW, my gripe with a certain poster is due to his misleading statements, in fact , his darn right lies, plus his inability to accept that he's wrong, even when proven to be 100%. He has also stifled many threads over the years, and ruined open debate, preferring to make it " all about him " rather than the company. He is a despicable individual with a very severe personality disorder... Lets just leave it there. As for any verbal gymnastics required, i don't think there is the need for any . Like many other posters, Lozan is sick and tired of someones continual lies. His reference is not directed at the stock, its directed at the same horrible little man that i mentioned above who has advocated his buy buy buy nonsense for about 7 years now. Anyone who was unfortunate enough to listen to the idiot, will now be out of pocket and trapped. I'm also bored of the idiot, so lets try and leave him to lick his wounds, in the hope that he will not come back on here posting his utter rubbish ever again. I hope that the beatings he takes every time he does appear, will help him to stay away. | tosh123 | |
23/8/2018 08:45 | Yes. You are CERTAIN I will learn. Keep compounding the hypocrisy :) | wigwammer | |
23/8/2018 08:39 | Stick around a while, and you'll LEARN | the real lozan | |
23/8/2018 08:38 | Boom, for clarity, this is what i have heard from someone very close to the company, so please take it as exactly that eg ;- here say. ( but i trust the source ). DE wanted to take the company down a more commercial route and realise some shareholder value. I'm told that with the advent of Modi's discovery, that he wanted to split the two platforms into 2 separate companies, thereby accepting a licensing deal on Scib , and using some of the up front proceeds from that deal, to develop the Modi platform, thereby retaining 100% of the IP of Modi, and keeping all development " in house " and fully funded. ( whilst still retaining a much reduced financial interest in Scib ). Supposedly, there was an offer on the table for Scib, but RG was reluctant to consider it, preferring to raise more money ( a few times ) rather than get into bed with anyone else, and become fully financed for Modi's development. Because of the extremely differing views, one of them had to cede. DE 's health also played a part in his decision, however, the bottom line is that they were poles apart with their vision of how the company should progress, so one had to go. | tosh123 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions